Impedimed Limited Stock Market Value
| IPDQF Stock | USD 0.03 0.00 0.00% |
| Symbol | ImpediMed |
ImpediMed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ImpediMed's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ImpediMed.
| 12/21/2025 |
| 01/20/2026 |
If you would invest 0.00 in ImpediMed on December 21, 2025 and sell it all today you would earn a total of 0.00 from holding ImpediMed Limited or generate 0.0% return on investment in ImpediMed over 30 days. ImpediMed is related to or competes with Positron Corp, Marpai, Perimeter Medical, PetVivo Holdings, Celyad Oncology, and Finch Therapeutics. ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy de... More
ImpediMed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ImpediMed's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ImpediMed Limited upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0381 | |||
| Maximum Drawdown | 86.44 |
ImpediMed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ImpediMed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ImpediMed's standard deviation. In reality, there are many statistical measures that can use ImpediMed historical prices to predict the future ImpediMed's volatility.| Risk Adjusted Performance | 0.041 | |||
| Jensen Alpha | 0.4723 | |||
| Total Risk Alpha | (1.15) | |||
| Treynor Ratio | 0.4223 |
ImpediMed Limited Backtested Returns
ImpediMed is out of control given 3 months investment horizon. ImpediMed Limited holds Efficiency (Sharpe) Ratio of 0.15, which attests that the entity had a 0.15 % return per unit of risk over the last 3 months. We were able to break down and collect data for seventeen different technical indicators, which can help you to evaluate if expected returns of 1.71% are justified by taking the suggested risk. Use ImpediMed Limited Standard Deviation of 13.41, risk adjusted performance of 0.041, and Market Risk Adjusted Performance of 0.4323 to evaluate company specific risk that cannot be diversified away. ImpediMed holds a performance score of 12 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 1.42, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ImpediMed will likely underperform. Use ImpediMed Limited information ratio, kurtosis, as well as the relationship between the Kurtosis and relative strength index , to analyze future returns on ImpediMed Limited.
Auto-correlation | Huge |
Perfect predictability
ImpediMed Limited has perfect predictability. Overlapping area represents the amount of predictability between ImpediMed time series from 21st of December 2025 to 5th of January 2026 and 5th of January 2026 to 20th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ImpediMed Limited price movement. The serial correlation of 9.223372036854776E16 indicates that 9.223372036854776E16% of current ImpediMed price fluctuation can be explain by its past prices.
| Correlation Coefficient | 92233.7 T | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
ImpediMed Limited lagged returns against current returns
Autocorrelation, which is ImpediMed pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ImpediMed's pink sheet expected returns. We can calculate the autocorrelation of ImpediMed returns to help us make a trade decision. For example, suppose you find that ImpediMed has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ImpediMed regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ImpediMed pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ImpediMed pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ImpediMed pink sheet over time.
Current vs Lagged Prices |
| Timeline |
ImpediMed Lagged Returns
When evaluating ImpediMed's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ImpediMed pink sheet have on its future price. ImpediMed autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ImpediMed autocorrelation shows the relationship between ImpediMed pink sheet current value and its past values and can show if there is a momentum factor associated with investing in ImpediMed Limited.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in ImpediMed Pink Sheet
ImpediMed financial ratios help investors to determine whether ImpediMed Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ImpediMed with respect to the benefits of owning ImpediMed security.